Healthcare Industry News: Oncology information system
News Release - May 21, 2008
Still River Systems Announces Operation of the World's Highest Magnetic Field CyclotronLITTLETON, Mass., May 21 (HSMN NewsFeed) -- Still River Systems announces the successful development and operation of the world's highest magnetic field cyclotron as part of the development of its Monarch250(TM) proton therapy system. This cyclotron is operating at 10 Tesla and conclusively demonstrates that cyclotrons at this high field strength can be designed and optimized for proton radiation therapy. By increasing the operating magnetic field, Still River Systems is developing a cyclotron that weighs less than 20 tons, a 90% reduction over the current generation of proton therapy cyclotrons. "We are excited to report this technical breakthrough," says Kenneth Gall, Ph.D., Chief Technology Officer and Founder of Still River Systems. "While magnets of this strength are already in use in medical applications, the challenge has been to operate a cyclotron at this very large magnetic field."
Conventional proton radiation therapy cyclotrons are based on non-superconducting technology, and operate at low magnetic fields. In 2004, Still River Systems partnered with the Massachusetts Institute of Technology (MIT) to develop this next generation of proton therapy cyclotron using high magnetic field technology currently used in research and Magnetic Resonance Imaging (MRI) applications. "Our goal is to make proton radiation therapy treatment available to hospitals and cancer centers worldwide. This was only possible through a significant reduction in the cost and size of the proton therapy equipment and facility which can be achieved by using high-magnetic field technology," says Marc Buntaine, Chief Executive Officer of Still River Systems.
About The Monarch250
The Monarch250 is the next generation of proton radiation therapy systems. Based on Still River Systems high-magnetic field cyclotron, combined with proven proton therapy technology, the Monarch250 is being integrated with well established clinical systems such as patient radiographic and cone beam CT imaging, high-precision robotic treatment couch, Oncology information systems and treatment planning systems. The compact, precise and affordable design of the Monarch250 proton therapy system provides the most versatile proton treatment capabilities, enhancing existing department capacity. For large multiple room proton centers, the Monarch250 unique configuration of one-cyclotron for each room will provide the most reliable, efficient and economical approach to proton therapy. The Monarch250 has not been cleared for commercial distribution/clinical use by the US Food and Drug Administration and is currently in development.
About Still River Systems
Still River Systems, based in Littleton, Massachusetts, is dedicated to providing physicians and their patients access to high quality, cost-effective proton therapy solutions, and to help establish this superior treatment modality as a standard of care for patients worldwide. Still River Systems is developing the Monarch250, an affordable, precise and compact proton therapy system for cancer treatment. For more information on Still River Systems and the Monarch250 Proton Therapy System, please call 978-540-1500 or visit their website @ http://www.StillRiverSystems.com.
Source: Still River Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.